Published by Josh White on 13th March 2018
(ShareCast News) - Advanced transdermal technology-focussed healthcare company Futura Medical announced positive interim data from its pharmacokinetic study, which formed the initial stage of the Phase III programme of MED2002 - its topical gel for erectile dysfunction.
URL: http://www.digitallook.com/dl/news/story/27187897/...